Modulators of melanocortin receptor
US7790719B2 · kind B2 · utility
6Cited by
4References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2007 |
| Grant date | Sep 7, 2010 |
| Priority date | — |
| Expiry date | May 8, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides compounds and methods for treating melanocortin receptor associated disorders, such as weight loss disorders including cachexia resulting from cancer and other chronic illnesses. The compounds are represented by formula I:wherein X is oxygen or sulfur; G is G1 or G2:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.